Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Pharmaceutical industry leaders, under the aegis of Association of Industrial Pharmacists of Nigeria (NAIP), have raised ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the ...

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

The US president has already attacked Ireland’s pharmaceuticals industry. Australia fears our medicines could be next.

Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience. As of fiscal year-end 2024, Thermo ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...